Open Medicine
(Jan 2021)
Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
Lv Yuankai,
Cao Zhuo,
Pan Jiongwei,
Gong Enhui,
Zheng Hao,
Cai Xiaoping
Affiliations
Lv Yuankai
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Cao Zhuo
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Pan Jiongwei
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Gong Enhui
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Zheng Hao
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
Cai Xiaoping
Department of Respiratory, Lishui People’s Hospital, No.15 Dazhong Road, Liandu District, Lishui, Zhejiang, 323000, People’s Republic of China
DOI
https://doi.org/10.1515/med-2021-0202
Journal volume & issue
Vol. 16,
no. 1
Abstract
Read online
The aim of the present work was to investigate the clinical efficacy of first-line chemotherapy regimens in the treatment of advanced non-small cell lung cancer (NSCLC) through a comprehensive network meta-analysis (NMA).
Keywords
WeChat QR code
Close
